SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
relapse
Journals
14
1
Medicine
2
BMC infectious diseases
3
Journal of visualized experiments : JoVE
4
BMJ
5
Neuropsychiatric disease and treatment
6
The International journal on drug policy
7
administration and policy in mental health
8
Haematologica
9
bmc nephrology
10
international orthodontics
11
journal of nuclear medicine : official publication, society of nuclear medicine
12
international journal of clinical and experimental pathology
13
world journal of hepatology
14
journal of cranio-maxillo-facial surgery : official publication of the european association for cranio-maxillo-facial surgery
Research Groups
0
No Research Group Connected
Bibliographies
119
1
Locking Away "Recidivism".
2
FDG-PET/CT AS A NON-INVASIVE BIOMARKER FOR ASSESSING ADEQUACY OF TREATMENT AND PREDICTING RELAPSE IN PATIENTS TREATED FOR PULMONARY TUBERCULOSIS.
3
Difficulties In Emotion Regulation During Rehabilitation For Alcohol Addiction: Correlations With Metacognitive Beliefs About Alcohol Use And Relapse Risk.
4
The discordance pattern of molecular sub-types between primary and metastatic sites in Chinese breast cancer patients.
5
Capital depreciation: The lack of recovery capital and post-release support for prisoners leaving the Drug Recovery Wings in England and Wales.
6
Disclosing Hemolymph Collection and Inoculation of Metarhizium Blastospores into Rhipicephalus Microplus Ticks Towards Invertebrate Pathology Studies.
7
Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection.
8
The stability of surgically assisted rapid maxillary expansion (SARME): A systematic review.
9
the profile and treatment outcomes of sputum smear positive pulmonary tuberculosis re-treatment cases, in a district medical college of west bengal, india
10
dendritic cell therapy in allogeneic-hematopoietic cell transplantation setting: an effective strategy towards better disease control?
11
evaluation of factors associated with relapse in telaprevir-based triple therapy for chronic hepatitis c
12
comparative study of skeletal stability between postoperative skeletal intermaxillary fixation and no skeletal fixation after bilateral sagittal split ramus osteotomy: an 18 months retrospective study
13
religious affiliation as a predictor of involuntary psychiatric admission: a brazilian one-year follow-up study
14
risk factors for relapse of resectable pathologic n2 non small lung cancer and prediction model for time-to-progression
15
Resistance-associated substitutions and response to treatment in a chronic hepatitis C virus infected-patient: an unusual virological response case report.
16
Helping Clients Think Through Their Causal Models
17
Traitement du purpura thrombopénique immunologique : étude rétrospective de 40 patients
18
Factors associated with post-relapse survival in patients with recurrent cervical cancer: the value of the inflammation-based Glasgow Prognostic Score.
19
Cardiotrophin-1: A new predictor of atrial fibrillation relapses after successful cardioversion.
20
Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data
21
Characterization of hepatitis C virus resistance to grazoprevir reveals complex patterns of mutations following on-treatment breakthrough that are not observed at relapse
22
Antibody-Negative Relapse of Goodpasture Syndrome with Pulmonary Hemorrhage
23
Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data
24
Characterization of hepatitis C virus resistance to grazoprevir reveals complex patterns of mutations following on-treatment breakthrough that are not observed at relapse
25
The role of salvage brachytherapy for local relapse after external beam radiotherapy for prostate cancer.
26
Impact of laterality and mucinous histology on relapse-free and overall survival in a registry-based colon cancer series
27
A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT.
28
Efficacy and safety of a bortezomib and reduced-intensity cytarabine-based protocol, TMC ALLR1, for relapsed childhood ALL in India
29
Integrating expert opinion with clinical trial data to extrapolate long-term survival: a case study of CAR-T therapy for children and young adults with relapsed or refractory acute lymphoblastic leukemia.
30
Re-Configuring Identity Postpartum and Sustained Abstinence or Relapse to Tobacco Smoking.
31
The HELPER programme: HEalthy Living and Prevention of Early Relapse – three exploratory randomised controlled trials of phase-specific interventions in first-episode psychosis
32
Gender Differences in the Association Between Romantic Relationships and Relapse Among Individuals in Early Recovery in Oxford House
33
Dietary Supplements on Controlling Multiple Sclerosis Symptoms and Relapses: Current Clinical Evidence and Future Perspectives.
34
Managing myelofibrosis (MF) that "blasts" through: advancements in the treatment of relapsed/refractory and blast-phase MF.
35
Understanding Implementation of a Digital Self-Monitoring Intervention for Relapse Prevention in Psychosis: Protocol for a Mixed Method Process Evaluation.
36
Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depression
37
The prevalence, risk factors, and prognostic value of anxiety and depression in refractory or relapsed acute myeloid leukemia patients of North China.
38
Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation.
39
'Real-world' Australian experience of pomalidomide for relapsed and refractory myeloma.
40
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.
41
Comparative study between paired primary and relapsed breast cancer patients based on clinicopathological features and molecular subtypes of breast cancer in Babylon Province
42
A claims-based algorithm to reduce relapse and cost in schizophrenia.
43
A mathematical model for assessing the effectiveness of controlling relapse in Plasmodium vivax malaria endemic in the Republic of Korea.
44
Giving and receiving social support in online substance use disorder forums: How self-efficacy moderates effects on relapse.
45
Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients.
46
Prognostic factors associated with locoronal relapses, metastatic relapses, and death among women with breast cancer. Population-based cohort study
47
Associations among smoking, MGMT hypermethylation, TP53-mutations, and relapse in head and neck squamous cell carcinoma.
48
Clinicopathological and genetic features of limited-stage diffuse large B-cell lymphoma with late relapse: targeted sequencing analysis of gene alterations in the initial and late relapsed tumors.
49
Analysis of Japanese patients from the AUGMENT phase III study of lenalidomide + rituximab (R) vs. rituximab + placebo in relapsed/refractory indolent non-Hodgkin lymphoma.
50
Retreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter retrospective study.
51
Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review
52
Longer Follow-Up Confirms Relapse-Free Survival Benefit With Adjuvant Dabrafenib Plus Trametinib in Patients With Resected V600-Mutant Stage III Melanoma.
53
High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease.
54
Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse
55
Real world Italian experience of pomalidomide plus low-dose dexamethasone in the relapsed and refractory myeloma setting: extended follow-up of a retrospective multicenter study by the 'Rete Ematologica Pugliese E Basilicata'
56
Unusual relapse of acute myeloid leukemia: granulocytic sarcoma presenting as an acute paraplegia
57
Study on effectiveness of gemcitabine, dexamethasone, and cisplatin (GDP) for relapsed or refractory AIDS-related non-Hodgkin's lymphoma
58
Relapse of erysipelas following treatment with prednisolone or placebo in addition to antibiotics: a 1-year follow-up
59
Low incidence of thromboembolism in relapsed/refractory myeloma patients treated with thalidomide without thromboprophylaxis in Taiwan
60
prognosis of the relapse of ovarian cancer based on the computer-assisted morphometric study of ovarian carcinoma samples stained with various histochemical markers
61
conventional-dose versus high-dose chemotherapy for relapsed germ cell tumors
62
impact of naltrexone preventation of relapse opiate dependence
63
comparison of intramuscular betamethasone and oral pprednisone in the prevention of relapse of acute asthma
64
isolated skin relapse of philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic stem cell transplant
65
genomic analyses reveal the common occurrence and complexity of plasmodium vivax relapses in cambodia
66
evaluation of clinical course, rirsk factors for relapse and long-term outcome of children with primary nephrotic syndrome
67
relapse after oral terbinafine therapy in dermatophytosis: a clinical and mycological study
68
bendamustine hcl for the treatment of relapsed indolent non-hodgkin’s lymphoma
69
dramatic clinical response of relapsed metastatic extramammary paget’s disease to trastuzumab monotherapy
70
the infection returns: a case of pulmonary sporotrichosis relapse after chemotherapy
71
effectiveness of cognitive – behavioral therapy on the decreasing of relapse of addiction to norcotic in the collegian students and it s influence on the increasing of their achievement motivation
72
fatores associados à recidiva em hanseníase em mato grosso factores asociados a recidiva en hanseníasis en mato grosso, centro-oeste de brasil factors associated to relapse of leprosy in mato grosso, central-western brazil
73
the role of allogeneic stem cell transplantation in relapsed/refractory hodgkin's lymphoma patients
74
vascular endothelial growth factor as a marker of development of relapses in the postoperative period in kidney and bladder tumors
75
relapse of polymyalgia rheumatica following adjuvanted influenza vaccine: a case-based review
76
very late local relapse of ewing's sarcoma of the head and neck treated with aggressive multimodal therapy
77
current role of autologous and allogeneic stem cell transplantation for relapsed and refractory hodgkin lymphoma
78
carfilzomib boosted combination therapy for relapsed multiple myeloma
79
addiction and drug abuse: the role of automatic thoughts, coping strategies and neuroticism in relapse
80
testicular involvement in relapsed hodgkin lymphoma
81
scientific productions of the health area in the alcoholism and relapse theme: a narrative review
82
multimodal hazard rate for relapse in breast cancer: quality of data and calibration of computer simulation
83
neurophysiological correlates of response inhibition predict relapse in detoxified alcoholic patients: some preliminary evidence from event-related potentials
84
retreatment with pegylated interferon alpha-2a and ribavirin in patients with chronic hepatitis c who have relapsed or not responded to a first course of pegylated interferon-based therapy
85
tratamento do mieloma múltiplo recidivado relapsed multiple myeloma treatment
86
metastatic pattern, local relapse, and survival of patients with myxoid liposarcoma: a retrospective study of 45 patients
87
an intensive approach to treatment for older patients with relapsed isolated npm1 mutated aml
88
the effectiveness of the mindfulness based relapse prevention (mbrp) model on relapse prevention and coping skills enhancement in people with substance dependency
89
peripheral blood wt1 expression predicts relapse in aml patients undergoing allogeneic stem cell transplantation
90
efficacy and pharmacologic data of second-generation tyrosine kinase inhibitor nilotinib in bcr-abl-positive leukemia patients with central nervous system relapse after allogeneic stem cell transplantation
91
gemcitabine, navelbine, and doxorubicin as treatment for patients with refractory or relapsed t-cell lymphoma
92
comparison of fecal calprotectin methods for predicting relapse of pediatric inflammatory bowel disease
93
the role of human papillomavirus typization and cytology in early detection of relapse of cervical intraepithelial neoplasia
94
inotuzumab ozogamicin: a cd22 mab–drug conjugate for adult relapsed or refractory b-cell precursor acute lymphoblastic leukemia
95
daunorubicin, cytarabine, and cladribine regimen plus radiotherapy and donor lymphocyte infusion for extramedullary relapse of acute myeloid leukemia after hematopoietic stem cell transplantation
96
the effectiveness of interventions based on positive psychotherapy on improving coping styles, relapse prevention in individuals with substance use disorder
97
complete psa remission without adjuvant therapy after secondary lymph node surgery in selected patients with biochemical relapse after radical prostatectomy and pelvic lymph node dissection
98
risk factors associated with gastroesophageal reflux disease relapse in primary care patients successfully treated with a proton pump inhibitor
99
sinonasal lymphoma presenting as a probable sanctuary site for relapsed b acute lymphoblastic leukaemia: a case report and review of the literature
100
a phase ib/ii study of ganetespib with doxorubicin in advanced solid tumors including relapsed-refractory small cell lung cancer
101
autologous bone marrow transplantation in patients relapsed one year after r-chop?